Simultaneous estimation of amlodipine besylate and olmesartan medoxomil by first order derivative spectroscopy from tablet

International Journal of PharmTech Research

Volumn 3, Issue 2, 2011, Pages 668-675

  Patil, Pournima S ^a   Kulkarni, Pramodini D ^a   Burkul, Mallappa S ^a   More, Harinath N ^b   Pishawikar, Sachin A ^b  

^a Malkapur Karad Maharashtra Pin 415110   (India)

^b BHARATI VIDYAPEETH COLLEGE OF PHARMACY   (India)

Author keywords

Amlodipine besylate; Olmesartan medoxomil; Spectroscopy

Indexed keywords

AMLODIPINE BESYLATE; OLMESARTAN;

ARTICLE; DRUG DETERMINATION; MEASUREMENT; SPECTROPHOTOMETRY; SPECTROSCOPY; TABLET;

EID: 84856275915     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Dongyang L., Pei H., and Matsushima N., Quantitative determination of olmesartan in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. J. Chromatography B. 2007, 856, 190-197.
2. Tomonori M., Hidetoshi K., Naoto F., Michinobu O., Takao K., Fumiyo K. Identification of degradation product in stressed tablet of olmesartan medoxomil by HPLC hyphenated techniques. J. Pharm Biomed Anal.2008,47,553-559.
3. Shah N.J., Sahagia B.N., Shah R.R., Patel N.M. Development and validation of simultaneous HPTLC method for the estimation of olmesartan medoxomil and hydrochlorothiazide. Indian J. Pharm Sci.2007,69,834-836.
4. Yang Yu., Yan-ning Hou., Pharmacokinetics of olmesartan, a new Angiotensin II receptor blocker, in Chinese healthy subjects. Asian J. Pharmacodynamics and Pharmacokinetics. 2006, 6, 219-223.
5. Patel C.V., Khandhar A.P., Validated Absorption Factor Spectorphtometric and Reversed-Phase High-Peroformance Liqid Chromatographic Methods for the Determination of Ramipril and Olmesartan Medoxomil in Pharmaceutical Formulations. Eurasian J. Anal. Chem. 2007, 2,159-171.
6. Celebier M., Sacide A., Development of a CZE Method for the Determination of Olmesartan medoxomil in Tablets, Chromatographia, 2007, 66, 929-933.
7. Koike H., New pharmacologic aspects of CS-866, the newest Angiotensin II Receptor antagonist. Am. J. Cardiol. 2001, 87, 33C-36C.
8. Koike H., Sada T., Mizuno M. In vitro and in vivo pharmacology of Olmesartan medoxomil, an Angiotensin II type AT1 receptor antagonist. J. Hypertens. 2001,19, S3-S14.
9. Vaidya V.V., Shikha M.N. LC-MS-MS Determination of Olmesartan in Human Plasma. Chromatographia. 2008, 67, 147-150.
10. Hillaert S., De Grauwe K. Simultaneous determination of hydrochlorothiazide and several inhibitors of angiotensin-converting enzyme by capillary electrophoresis. J. Chromatography A. 2001, 924, 439-449.
11. British Pharmacopoeia, 2005,1, Dept. Of Health Scotish Home and Health Dept, Northen Irland,1993, 330.
12. Naidu K.R., Kale U.N., Shingare M.S. Stability indicating RP-HPLC method for simultaneous determination of amlodipine and benazepril hydrochloride from their combination drug product. J Pharm Biomed Anal 2005, 39, 147-155.
13. Chaudhari B.G., Patel N.M., Shah P.B. Stability indicating RP-HPLC method for simultaneous determination of atorvastatin and amlodipine from their combination drug products. Chem Pharm Bull 2007, 55, 241-246.
14. Sahu R, Patel V.B. Simultaneous spectrophotometric determination of amlodipine besylate and atorvastatin calcium in binary mixture. Indian J Pharm Sci 2007, 69, 110-111.
15. Shah D.A., Bhatt K.K., Shankar M.B., Mehta R.S., Gandhi T.R., Baldania S.L. RP-HPLC determination of atorvastatin calcium and amlodipine besylate combination in tablets. Indian J Pharm Sci 2006, 68, 796-799.
16. Chaudhari B.G., Patel N.M., Shah P.B. Simultaneous estimation of atorvastatin and amlodipine from formulation by HPTLC. Indian Drugs 2006, 43, 649-655.
17. Kasture A.V., Ramteke M. Simultaneous UV-Spectrophotometric method for the estimation of atenolol and amlodipine besylate in combined dosage form. Ind J Pharm Sci 2006, 68, 394-396.
18. Gohil K., Trivedi P., Molvi KI. Spectrophotometric analysis of amlodipine besylate in bulk and tablet dosage form. Ind J Pharm Sci 2005, 67, 376-378.
19. Mahadik K.R., Agrawal H., Kaul N. Simultaneous HPTLC estimation of amloipine besylate and losartan potassium in tablet dosage form. Indian Drugs 2004, 41, 32-35.
20. Kulkarni A.P., Gat G.V., Pimple S.V., Joshi M.A. HPLC method for determination of losartan potassium and amlodipine besylate in tablets. Indian Drugs 2003, 40, 298-299.
21. Zarapkar S., Kanyawar N. Simultaneous estimation of amlodipine and losartan potassium in pharmaceutical dosage by RP-HPLC. Indian Drugs 2002, 39, 338-341.
22. Gowri N., Vaidhyalingam V., Shantha A. Simultaneous estimation of amlodipine and benazepril tablets by RP-HPLC. Indian Drugs 2002, 39, 532-535.
23. Dhake A.S., Kasture V.S., Syed M.R. Spectrophotometric method for estimation of amlodipine besylate and enalapril maleate in tablets. Indian Drugs 2002, 39, 14-17.
24. Patki R.V., Tamhankar C.P., Tipnis H.P. Simple and rapid high performance liquid chromatographic estimation of amlodipine from pharmaceutical dosages. Indian Drugs 1994, 31, 560-561.
25. Sane R.T., Desai A.J., Valiyare G.R., Ghadge A.J. High performance liquid chromatographic determination of amlodipine besylate from its pharmaceutical preparation. Indian Drugs 1993, 30, 501-505.
26. Sridhar K., Sastry C.S.P., Reddy M.N., Sankar D.G., Srinivas K.R. Spectrophotometric Determination of Amlodipine Besylate in Pure Forms and Tablets, Analytical Letteres 1997,30, 121-133.
27. Rahman N., and Azmi S.N.H., Spectrophotometric method for the determination of amlodipine besylate with ninhydrin in drug formulations. II Farmaco, 2001,56, 731-735.
28. Kasture A.V., Ramteke M., Simultaneous UV-Spectrophotometric method for the estimation of atenolol and amlodipine besylate in combined dosage form. Ind. J. Pharm. Sci. 2006,68, 394-396.
29. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Stability testing of new drug substances and products, Q1A(R2), Current step 4 version dated 6 February 2003, http://www.ich.org.